ALLR vs JCI · P/E 0.0, rev $25.0K vs P/E 44, rev $23.60B
Allarity Therapeutics Inc (ALLR) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the ALLR and JCI stock pages for the full models.
Not investment advice.